CORRESP Filing
REVELATION BIOSCIENCES, INC.
Date: May 22, 2025 · CIK: 0001810560 · Accession: 0001213900-25-046844
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287423
Letter
VIA EDGAR AND E-MAIL Office of Life Sciences Division of Corporate Finance F. Street, N.E. Washington, DC 20549-7010 Re: Revelation Biosciences, Inc. Registration Statement on Form S-1; Commission File No. 333-287423
Dear Mr. Campbell:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Revelation Biosciences Inc. (the "Company") hereby requests that the effectiveness of the Company's Registration Statement on Form S-1 (File No. 333-287423) be accelerated by the U.S. Securities and Exchange Commission to 5:00 p.m. Eastern Time on Tuesday, May 27, 2025, or as soon thereafter is practicable.
The Company hereby authorizes Joseph P. Galda of J.P. Galda & Co. to orally modify or withdraw this request for acceleration. Please contact Mr. Galda at (215) 815-1534 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Thank you for your courtesy and cooperation in this matter.
Very
truly yours,
REVELATION
BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm REVELATION BIOSCIENCES, INC. 4660 La Jolla Village Drive, Suite 100 San Diego, CA 92122 May 22, 2025 VIA EDGAR AND E-MAIL Mr. Alan Campbell Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549-7010 Re: Revelation Biosciences, Inc. Registration Statement on Form S-1; Commission File No. 333-287423 Dear Mr. Campbell: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Revelation Biosciences Inc. (the "Company") hereby requests that the effectiveness of the Company's Registration Statement on Form S-1 (File No. 333-287423) be accelerated by the U.S. Securities and Exchange Commission to 5:00 p.m. Eastern Time on Tuesday, May 27, 2025, or as soon thereafter is practicable. The Company hereby authorizes Joseph P. Galda of J.P. Galda & Co. to orally modify or withdraw this request for acceleration. Please contact Mr. Galda at (215) 815-1534 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Thank you for your courtesy and cooperation in this matter. Very truly yours, REVELATION BIOSCIENCES, INC. By: /s/ Chester S. Zygmont, III Chester S. Zygmont, III, CFO